Published 4 months ago • loading... • Updated 4 months ago
Clorox Reports Q2 Fiscal Year 2026 Results, Confirms Outlook
Clorox's Q2 sales fell 1% due to a temporary inventory drawdown linked to ERP changes and lower consumption, while confirming acquisition of GOJO to expand hygiene portfolio.
On Feb. 3, 2026, The Clorox Company reported second-quarter fiscal 2026 results ending December 31, 2025, with net sales down 1% to $1670 million and diluted EPS falling 16% to $ 1.29.
Pulling shipments forward before the system change resulted in a temporary inventory correction, management says, which translates to about 7.5 points of fiscal year 2026 sales decline.
Segment adjusted EBIT dropped 54%, gross margin fell 60 basis points to 43.2%, while International rose 7% and Health and Wellness grew 2% on Wednesday.
Following the results Wednesday, shares fell after Clorox reaffirmed fiscal 2026 adjusted EPS guidance of $5.95–$6.30 and sales guidance of $6.394 billion–$6.678 billion, with a live webcast scheduled.
The Clorox Company warned of regulatory approval and integration risks tied to the proposed acquisition of GOJO Industries, expected to close before fiscal year 2026.